The global brain computer interface market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.9 Billion by 2033, exhibiting a growth rate (CAGR) of 10.95% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 2.2 Billion |
Market Forecast in 2033 | USD 5.9 Billion |
Market Growth Rate (2025-2033) | 10.95% |
A brain computer interface (BCI) is a system used for acquiring, analyzing, and translating brain signals into commands using an artificial output device. This device assists in replacing, restoring, enhancing, supplementing, and improving the functions of the central nervous system (CNS). BCI replaces or restores the useful function of individuals suffering from neuromuscular disorders, such as cerebral palsy, amyotrophic lateral sclerosis, or spinal cord injury. It is also useful for rehabilitation after stroke or other disorders. As it finds extensive application in communicating and controlling patients with severe paralysis or in the locked-in syndrome (LIS), its demand is escalating around the world.
The rising geriatric population, coupled with the increasing prevalence of neurodegenerative disorders such as epilepsy and Alzheimer’s and Parkinson’s diseases, represents one of the key factors strengthening the growth of the market. Additionally, there is a rise in the integration of BCI technologies with several healthcare applications. This, in confluence with the increasing focus on using BCI technologies to control internet of things (IoT) devices and virtual reality (VR) applications, is propelling the market growth. Moreover, on account of its high accuracy and reliability and improved security monitoring, BCI technology finds application in controlling smart home applications and activities, such as opening and closing doors and windows and operating the television or music system. Furthermore, technological advancements in bio-sensing, nanotechnology, bio-signal processing, and neuro-imaging techniques, along with increasing investments in research and development (R&D) activities, are offering a positive outlook to the market. Besides this, the increasing adoption of BCI in the defense and military sector is anticipated to stimulate the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global brain computer interface market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product and application.
Breakup by Product:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Brain Monitoring Inc., ANT Neuro, Compumedics Limited, EMOTIV, Medtronic plc, Natus Medical Incorporated, NeuroSky Inc., Nihon Kohden Corporation and NIRx Medical Technologies LLC.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Advanced Brain Monitoring Inc., ANT Neuro, Compumedics Limited, EMOTIV, Medtronic plc, Natus Medical Incorporated, NeuroSky Inc., Nihon Kohden Corporation and NIRx Medical Technologies LLC |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global brain computer interface market was valued at USD 2.2 Billion in 2024.
We expect the global brain computer interface market to exhibit a CAGR of 10.95% during 2025-2033.
The high prevalence of neurodegenerative disorders, along with the rising applications of BCI system in communicating and controlling patients with severe paralysis or in the locked-in syndrome, are primarily driving the global brain computer interface market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective treatment for neurodegenerative disorders to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby limiting the demand for brain computer interface system.
Based on the product, the global brain computer interface market has been segmented into invasive BCI, partially invasive BCI, and non-invasive BCI. Currently, non-invasive BCI holds the majority of the total market share.
Based on the application, the global brain computer interface market can be divided into healthcare, smart home control, communication and control, and entertainment and gaming. Among these, the healthcare sector exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global brain computer interface market include Advanced Brain Monitoring Inc., ANT Neuro, Compumedics Limited, EMOTIV, Medtronic plc, Natus Medical Incorporated, NeuroSky Inc., Nihon Kohden Corporation, and NIRx Medical Technologies LLC.